(Date:11/21/2009)... Germany, November 20,2009 / b3c newswire / - KI...n of a financing round, gaining two new investors ...same time KINAXO reports that Jrgen Schumacher has...sory board. , KINAXO shareholders Axel Ullrich, ...mpanys institutional investors Mountain Partners, ...
(Date:11/20/2009)...ly precise measurements of plasma lipoprotein conc...e spectroscopy (NMR), researchers led by Daniel Ch...Medical School in Boston, MA, the Framingham Heart... in Stockholm, Sweden and Oxford, England performe...nome among 17,296 women of European ancestry from ...
(Date:11/20/2009)...uestion in the origin of biological molecules like...ons of years ago from simple precursors. Now, in a...n Italy have reconstructed one of the earliest evo... from individual subunits using nothing but warm w...ne of the first biological molecules present, befo...
Breaking Biology News(10 mins):KINAXO Completes Financing Round to Enhance Biomarker Development 2KINAXO Completes Financing Round to Enhance Biomarker Development 3Genetic analysis helps dissect molecular basis of cardiovascular disease 2Even Steroid Free Bodybuilders Focus on Image 50797 1Even Steroid Free Bodybuilders Focus on Image 50797 2Farmers Insurance Annual Challenge 3A Be a Hero for Babies Day 28SM 29 50795 1Farmers Insurance Annual Challenge 3A Be a Hero for Babies Day 28SM 29 50795 2Farmers Insurance Annual Challenge 3A Be a Hero for Babies Day 28SM 29 50795 3The Psychology of Frailty 3A An Identity Crisis Among the Elderly Alzheimers Drug Discovery Foundations Dr Howard Fillit to Co Chair Symposium 50793 1The Psychology of Frailty 3A An Identity Crisis Among the Elderly Alzheimers Drug Discovery Foundations Dr Howard Fillit to Co Chair Symposium 50793 2(Date:11/20/2009)...d Latin American countries have an opportunity to ...Researchers from the University of Valencia (UV), ... studied the productive fabric of the Spanish biot...,s food and plant sectors have more clout than tho...y as applied to food and plants has been overlooke...
(Date:11/20/2009)..., SEATTLE, Nov. 20 Ce... announced today that the Ninth Circuit Court of A...led that CTI should be allowed to pursue all of it...back to the District Court for trial. CTI filed a...ird-party reimbursement consultant for CTI,s produ...
(Date:11/19/2009)... SEATTLE, Nov. 19 Omeros...dited financial results for the third quarter ende...eptember 30, 2009, Omeros reported a net loss of $...net loss of $7.4 million, or $2.54 per share, for ... September 30, 2009, the Company reported a net lo...
(Date:11/19/2009)..., MALVERN, Pa. and WALTHAM, Mass., Nov. 19 /PRN...Decision Resources find that the leading driver of...urope is broad-spectrum activity against gram-posi...ty of organisms that can cause nosocomial pneumoni...ook primarily for agents that provide appropriate ...
Breaking Biology Technology:Spanish biotechnology should focus on food and plant sectors to be more competitive 2Cell Therapeutics Wins Federal Appeal to Pursue $22.8 Million Claim Against The Lash Group 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 3Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 4Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 5Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 6Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 7Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 8Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 2Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 3 Other News: